Cargando…

Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups

INTRODUCTION: Glioblastoma with oligodendroglioma component (GBM-O) was recognized as a histologic pattern of glioblastoma (GBM) by the World Health Organization (WHO) in 2007 and is distinguished by the presence of oligodendroglioma-like differentiation. To better understand the genetic underpinnin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinrichs, Benjamin H., Newman, Scott, Appin, Christina L., Dunn, William, Cooper, Lee, Pauly, Rini, Kowalski, Jeanne, Rossi, Michael R., Brat, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711079/
https://www.ncbi.nlm.nih.gov/pubmed/26757882
http://dx.doi.org/10.1186/s40478-015-0270-7
_version_ 1782409914836058112
author Hinrichs, Benjamin H.
Newman, Scott
Appin, Christina L.
Dunn, William
Cooper, Lee
Pauly, Rini
Kowalski, Jeanne
Rossi, Michael R.
Brat, Daniel J.
author_facet Hinrichs, Benjamin H.
Newman, Scott
Appin, Christina L.
Dunn, William
Cooper, Lee
Pauly, Rini
Kowalski, Jeanne
Rossi, Michael R.
Brat, Daniel J.
author_sort Hinrichs, Benjamin H.
collection PubMed
description INTRODUCTION: Glioblastoma with oligodendroglioma component (GBM-O) was recognized as a histologic pattern of glioblastoma (GBM) by the World Health Organization (WHO) in 2007 and is distinguished by the presence of oligodendroglioma-like differentiation. To better understand the genetic underpinnings of this morphologic entity, we performed a genome-wide, integrated copy number, mutational and transcriptomic analysis of eight (seven primary, primary secondary) cases. RESULTS: Three GBM-O samples had IDH1 (p.R132H) mutations; two of these also demonstrated 1p/19q co-deletion and had a proneural transcriptional profile, a molecular signature characteristic of oligodendroglioma. The additional IDH1 mutant tumor lacked 1p/19q co-deletion, harbored a TP53 mutation, and overall, demonstrated features most consistent with IDH mutant (secondary) GBM. Finally, five tumors were IDH wild-type (IDHwt) and had chromosome seven gains, chromosome 10 losses, and homozygous 9p deletions (CDKN2A), alterations typical of IDHwt (primary) GBM. IDHwt GBM-Os also demonstrated EGFR and PDGFRA amplifications, which correlated with classical and proneural expression subtypes, respectively. CONCLUSIONS: Our findings demonstrate that GBM-O is composed of three discrete molecular subgroups with characteristic mutations, copy number alterations and gene expression patterns. Despite displaying areas that morphologically resemble oligodendroglioma, the current results indicate that morphologically defined GBM-O does not correspond to a particular genetic signature, but rather represents a collection of genetically dissimilar entities. Ancillary testing, especially for IDH and 1p/19q, should be used for determining these molecular subtypes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-015-0270-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4711079
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47110792016-01-14 Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups Hinrichs, Benjamin H. Newman, Scott Appin, Christina L. Dunn, William Cooper, Lee Pauly, Rini Kowalski, Jeanne Rossi, Michael R. Brat, Daniel J. Acta Neuropathol Commun Research INTRODUCTION: Glioblastoma with oligodendroglioma component (GBM-O) was recognized as a histologic pattern of glioblastoma (GBM) by the World Health Organization (WHO) in 2007 and is distinguished by the presence of oligodendroglioma-like differentiation. To better understand the genetic underpinnings of this morphologic entity, we performed a genome-wide, integrated copy number, mutational and transcriptomic analysis of eight (seven primary, primary secondary) cases. RESULTS: Three GBM-O samples had IDH1 (p.R132H) mutations; two of these also demonstrated 1p/19q co-deletion and had a proneural transcriptional profile, a molecular signature characteristic of oligodendroglioma. The additional IDH1 mutant tumor lacked 1p/19q co-deletion, harbored a TP53 mutation, and overall, demonstrated features most consistent with IDH mutant (secondary) GBM. Finally, five tumors were IDH wild-type (IDHwt) and had chromosome seven gains, chromosome 10 losses, and homozygous 9p deletions (CDKN2A), alterations typical of IDHwt (primary) GBM. IDHwt GBM-Os also demonstrated EGFR and PDGFRA amplifications, which correlated with classical and proneural expression subtypes, respectively. CONCLUSIONS: Our findings demonstrate that GBM-O is composed of three discrete molecular subgroups with characteristic mutations, copy number alterations and gene expression patterns. Despite displaying areas that morphologically resemble oligodendroglioma, the current results indicate that morphologically defined GBM-O does not correspond to a particular genetic signature, but rather represents a collection of genetically dissimilar entities. Ancillary testing, especially for IDH and 1p/19q, should be used for determining these molecular subtypes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-015-0270-7) contains supplementary material, which is available to authorized users. BioMed Central 2016-01-13 /pmc/articles/PMC4711079/ /pubmed/26757882 http://dx.doi.org/10.1186/s40478-015-0270-7 Text en © Hinrichs et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hinrichs, Benjamin H.
Newman, Scott
Appin, Christina L.
Dunn, William
Cooper, Lee
Pauly, Rini
Kowalski, Jeanne
Rossi, Michael R.
Brat, Daniel J.
Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups
title Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups
title_full Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups
title_fullStr Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups
title_full_unstemmed Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups
title_short Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups
title_sort farewell to gbm-o: genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711079/
https://www.ncbi.nlm.nih.gov/pubmed/26757882
http://dx.doi.org/10.1186/s40478-015-0270-7
work_keys_str_mv AT hinrichsbenjaminh farewelltogbmogenomicandtranscriptomicprofilingofglioblastomawitholigodendrogliomacomponentrevealsdistinctmolecularsubgroups
AT newmanscott farewelltogbmogenomicandtranscriptomicprofilingofglioblastomawitholigodendrogliomacomponentrevealsdistinctmolecularsubgroups
AT appinchristinal farewelltogbmogenomicandtranscriptomicprofilingofglioblastomawitholigodendrogliomacomponentrevealsdistinctmolecularsubgroups
AT dunnwilliam farewelltogbmogenomicandtranscriptomicprofilingofglioblastomawitholigodendrogliomacomponentrevealsdistinctmolecularsubgroups
AT cooperlee farewelltogbmogenomicandtranscriptomicprofilingofglioblastomawitholigodendrogliomacomponentrevealsdistinctmolecularsubgroups
AT paulyrini farewelltogbmogenomicandtranscriptomicprofilingofglioblastomawitholigodendrogliomacomponentrevealsdistinctmolecularsubgroups
AT kowalskijeanne farewelltogbmogenomicandtranscriptomicprofilingofglioblastomawitholigodendrogliomacomponentrevealsdistinctmolecularsubgroups
AT rossimichaelr farewelltogbmogenomicandtranscriptomicprofilingofglioblastomawitholigodendrogliomacomponentrevealsdistinctmolecularsubgroups
AT bratdanielj farewelltogbmogenomicandtranscriptomicprofilingofglioblastomawitholigodendrogliomacomponentrevealsdistinctmolecularsubgroups